Ranalexin
| Name | Ranalexin |
| Category | Antimicrobial and Related Peptides |
| One Letter Code | FLGGLIKIVPAMICAVTKKC (Disulfide bridge: 14-20) |
| Three Letter Code | {Phe}{Leu}{Gly}{Gly}{Leu}{Ile}{Lys}{Ile}{Val}{Pro}{Ala}{Met}{Ile}{Cys}{Ala}{Val}{Thr}{Lys}{Lys}{Cys} (Disulfide bridge: 14-20) (Disulfide bridge: 14-20) |
| Molecular Weight | 2103.730 |
| Application | Antimicrobial & Antiviral Peptides |
| Desbois, Andrew P., Curtis G. Gemmell, and Peter J. Coote. "In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections." International journal of antimicrobial agents 35.6 (2010): 559-565. |
| Giacometti, A., et al. "In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia." Antimicrobial agents and chemotherapy 44.6 (2000): 1716-1719. |
| Clark, Douglas P., et al. "Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin." Journal of Biological Chemistry 269.14 (1994): 10849-10855. |